ClinicalTrials.gg
CompletedNCT06240923Updated Feb 5, 2024

"Three Dimensional Assessment of Maxillary Molars Following Distalization Using Two Different Approaches"

An interventional study of Maxillary molars distalization in Malocclusion, Angle Class II, sponsored by Ain Shams University. Completed at 1 site in Egypt. Open to participants aged 18 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-02-05.

Sponsored by Ain Shams University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 6 years 11 months after the study started (first participant enrolled Jan 2017, registered Dec 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Randomized
Ages
18 Years to 25 Years
Sex
All
01

Study summary

The goal of this controlled clinical trial is to compare the effects of two distalization methods supported by inter-radicular mini-screw for maxillary molars distalization in 20 adult patients with skeletal class I or moderate skeletal class II malocclusion, dental class II molar relationship, and full permanent dentition. The participants were randomly selected according to inclusion / exclusion criteria from the outpatient clinic of the Department of Orthodontics and Dentofacial Orthopedics, Faculty of dentistry, Ain Shams University, Cairo, Egypt. Selectees age was ranging from 18 to 25 years old.

An informed consent has been signed by each patient before his / her enrollment in this study, where the aim , methodology, and possible complications were been clearly described in details. This research has been thoroughly reviewed by the Research Ethics Committee of the Faculty of dentistry, Ain Shams University.

Read the detailed description

This study is a two-arm, parallel group, prospective randomized clinical trial with the allocation ratio of 1:1. The Consolidated Standards of Reporting Trials (CONSORT statement) were used as a guide for this study.

After reviewing the study protocol, the ethical committee at the Faculty of Dentistry, Ain-Shams University approved the study.

Before treatment was carried out, a detailed written Arabic consent was signed by all the subjects of both groups after full explanation of the aim of the study and the procedures.

This prospective clinical study was conducted on a total of 24 maxillary first molars.

No financial competing interests: This study was part of a Masters' degree in Orthodontics, Faculty of Dentistry, Ain-Shams University.

No financial conflicts of interest were declared. The study was self- funded by the principal investigator.

A sample size of 24 distalizing sites was selected and divided into two groups twelve each:

Group 1: Single coil spring. Group 2: Double coil spring.

02

Conditions studied

  • Malocclusion, Angle Class II

Keywords

  • Dental malocclusion
03

In context

Malocclusion, Angle Class II

124 studies on the registry are indexed under Malocclusion, Angle Class II; 19 are open to participants now.

This study's enrollment of 24 is below the median of 34 across 115 interventional studies indexed under Malocclusion, Angle Class II.

Browse Malocclusion, Angle Class II studies →

Lead sponsor

Ain Shams University is the lead sponsor of 1,950 studies on the registry; 429 are open to participants now.

Of its 35 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. All subjects are free from any dental anomalies as well as periodontal and systemic diseases that may influence orthodontic treatment.
  2. Adult patients with age ranging from 18 to 25 years.
  3. Full permanent dentition with exclusion of third molars.
  4. Both first and second maxillary molars are in occlusion.
  5. Skeletal class I, mild or moderate skeletal class II malocclusion.
  6. Full cusp or end to end class II molar relationship.
  7. Mild to moderate crowding in the upper dental arch and / or increased overjet.
  8. Normal or horizontal growth pattern.
  9. Non-extraction treatment plan.

Exclusion criteria

Exclusion Criteria:

  1. Previous orthodontic treatment.
  2. Treatment planning requiring orthognathic surgery.
  3. Severe molar rotation.
  4. Poor oral hygiene.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
24 participants (actual)

Study arms

  • Experimental
    Group 1: Single coil spring

    A single open coil spring was inserted between the maxillary second premolar and the maxillary first molar with a distalizing force 300 gm.

    Device: Maxillary molars distalization

  • Experimental
    Group 2: Double coil spring

    Two open coil springs were inserted. The first coil spring was inserted between the maxillary second premolar and the maxillary first molar with a distalization force 300gm, and the second coil spring was inserted between the maxillary first and maxillary second molar with a distalization force 200 gm.

    Device: Maxillary molars distalization

Interventions

  • DeviceMaxillary molars distalization

    Maxillary molars distalization by using a nickel titanium open coil spring as an posterior displacement device.

    Also known as: Posterior displacement of maxillary molars

06

What researchers measure

Primary outcomes

  1. The amount of maxillary molars distalization

    Primary outcome of this study is to determine the amount of maxillary molars linear distal movement distance measured in millimeters.

    Time frame: 8-10 months

  2. The type of maxillary molars distalization

    Molar tipping measured by the degree of the angle of tipping.

    Time frame: 8-10 months

Secondary outcomes

  1. Loss of anchorage

    Anterior linear displacement of the premolars measured in millimeters.

    Time frame: 8-10 months

07

Study locations

1 site
  • Ain Shams University
    Cairo, 11566, Egypt
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No — Study Protocol Statistical Analysis Plan (SAP) Informed Consent Form (ICF)

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2017 to primary completion in Mar 2022, 62 months.

Of 86 non-industry interventional studies with no phase under Malocclusion, Angle Class II, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 22. This study's 62 months is above that.

Counting every sponsor, half of 86 studies reached it within 15 months; a quarter within 11 and three quarters within 22.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 12, 2023
First posted
Feb 5, 2024
StartActual
Jan 2, 2017
Primary completionActual
Mar 16, 2022
CompletionActual
Jun 23, 2022
Last update
Feb 5, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 5, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06240923
Responsible party
Gihan Mohamed Anwar Mohamed Khattab (Dr., Ain Shams University) — Principal investigator
First posted
Feb 5, 2024
Start date
Jan 2, 2017
Primary completion
Mar 16, 2022
Completion
Jun 23, 2022
Last update
Feb 5, 2024

Study contacts

Noha I Abdelrahman, Assoc. Prof.
study director · Ain Shams University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion